A new digital tool for early detection of Alzheimer's disease
Augmem: A Novel Digital Cognitive Assessment for the Early Detection of Alzheimer's Disease
This study is testing a new digital tool called Augmem™ that helps spot early signs of Alzheimer's disease in a friendly and easy way, making it suitable for people of all ages and backgrounds.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augnition Labs LLC NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10688227 on NIH RePORTER |
What this research studies
This research focuses on developing a digital cognitive assessment tool called Augmem™ to improve the early detection of Alzheimer's disease. The tool aims to provide a more accurate and user-friendly method for assessing cognitive decline across various age groups and cultural backgrounds. By utilizing a series of validated memory tasks, the assessment seeks to identify early signs of Alzheimer's before traditional diagnostic methods can confirm the disease. This innovative approach could facilitate timely interventions and better management of Alzheimer's care.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who may be experiencing early signs of cognitive decline or are at risk for Alzheimer's disease.
Not a fit: Patients who are already diagnosed with advanced Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of Alzheimer's disease, allowing for timely therapeutic interventions.
How similar studies have performed: Previous research has shown success in using digital cognitive assessments for early detection of cognitive decline, indicating a promising avenue for this novel approach.
Where this research is happening
New York, United States
- Augnition Labs LLC — New York, United States (Active)
Researchers
- Principal investigator: Gilpin, Adele — Augnition Labs LLC
- Study coordinator: Gilpin, Adele
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.